Hence, inhibition of BRD4, p300, CHK1 and IKKα is predicted to impair progression of PC by inactivating BRD4-dependent enhancers and the consequent decline of AR-driven transcription by reduced AR binding to AREs. The gene discussed is AR; the disease is pachyonychia congenita.